COVID-19 update: GO FIRST announces scheme of 20% discount for the double vaccinated

To avail this offer, a passenger will have to book the tickets through GO FIRST website and mobile app, and then enter the promo code GOVACCI.

Moneycontrol News

December 22, 2021 / 18:05 IST

Representative image

Amid the omicron threat, GO FIRST--formerly GoAir--on December 22 announced a special 20 per cent discount on domestic flights for double-vaccinated passengers.

With this scheme, the private airliner is trying to encourage people to get fully vaccinated in the fight against the COVID-19 virus.

ALSO READ: 1.05 crore domestic air passengers in November, 17% higher than October: DGCA

To avail this offer, a passenger will have to book tickets through GO FIRST website and mobile app, and then enter the promo code GOVACCI. This discount is applicable for travel dates beyond 15 days from the date of booking.

"The past two years have been extremely difficult due to COVID-19, which has redefined the meaning of normal. We at GO FIRST are committed to ensuring the safety of all our stakeholders. We began by supporting the
vaccination of all our employees and now we encourage more people to get inoculated. We understand the need for vaccination, especially in
wake of the new variant and will continue to support India’s fight against COVID," said GO FIRST's CEO Kaushik Khona, through a press statement.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show